UF Health Cancer Center at Tandem meetings


The UF Health Cancer Center will be presenting at the Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, the combined annual meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). The meetings are Feb. 15-19 in Orlando and virtually.

The meeting addresses the most timely issues in hematopoietic cell transplantation and cellular therapy.

View the full program.

395 Risk Factors for Graft Failure in Children Undergoing Hematopoietic Cell Transplant (HCT) for Hemoglobinopathies, Bone Marrow Failure Syndromes, Severe Aplastic Anemia, Inborn Errors of Metabolism and Primary Immune Deficiencies
Presenting author: Mansi Dalal, M.D.
Authors include Reema Kashif, M.D., Jordan Milner, M.D.Jessica Cline, B.S., John Fort, M.D., Paul Castillo, M.D., John Ligon, M.D., Shu Wang, Ph.D.
and Biljana Horn, M.D.

372 Outcomes of Children with Severe Aplastic Anemia Who Received Hematopoietic Stem Cell Transplant Upfront or after Immunosuppressive Therapy
Authors include Reema Kashif, M.D., Jordan Milner, M.D., Mansi Dalal, M.D., Fan Yang, M.S., John Ligon, M.D., Jessica Cline, B.S., John Fort, M.D., Paul Castillo, M.D., and Biljana Horn, M.D.

118 Excellent Relapse-Free and Overall Survival in Pre-HCT Next-Generation Sequencing (NGS-MRD) Negative B-ALL Patients with or without TBI-Based Conditioning: Outcome of the Observational Arm of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) ONC1701 Endrad Study
Authors include Biljana Horn, M.D.

493 Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation (AHCT) for Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL): Secondary Analysis from Two Multicenter Randomized Controlled Trials (RCT) of Hematopoietic Cell Transplant Survivorship Interventions
Authors include John Wingard, M.D.

254 Mediport Use As an Acceptable Standard for CAR T Cell Infusion
Authors include John Ligon, M.D.

394 Determining the Safety and Efficacy of Prophylactic Defibrotide Administration in Children, Adolescents, and Young Adults with High-Risk Sickle Cell Disease (SCD) or Beta Thalassemia Major Following Myeloimmunoablative Conditioning (MAC) and Haploidentical Stem Cell Transplantation Utilizing CD34+ Selection and T-Cell (CD3) Addback (IND127812)
Authors include Jordan Milner, M.D.

80 Update on Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials
Authors include Jack Hsu, M.D.

LBA15 Comparison of Outcome Measures in Children Receiving Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies By Different Donor Types
Presenting author: Jordan Milner, M.D.
Authors include Mansi Dalal, M.D., Jessica Cline, B.S., John Fort, M.D., Jin-Ju Lee,
and Biljana Horn, M.D.

S-P1 Plenary [ASTCT/CIBMTR/EBMT Joint Plenary]: Lessons from the Pandemic: Are We Stronger?
John Wingard, M.D. (chair)
Wednesday, Feb. 15

WC-05 (CIBMTR Working Committee) Donor Health and Safety
Jack Hsu, M.D. (chair)
Wednesday, Feb. 15

NCI Cancer Center badge